CEO says Mylan isn't getting rich off EpiPen

The CEO of Mylan, which has come under fire for drastically raising the price of its EpiPen, says it's "not true" the company reaps huge profits off its lifesaving allergy treatment. That's according to testimony Heather Bresch is set to present at a ...
Source: WDSU.com - Health - Category: Consumer Health News Source Type: news